Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Sensei Biotherapeutics, Inc.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 8-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | | | 100.0% | 100.0% |
| Cost of goods sold | 165.2% | | | 200.0% | 154.9% |
| Gross profit | -65.2% | | | -100.0% | -54.9% |
| General and administrative | 65.2% | | | 48.9% | 54.9% |
| Depreciation | | | | 0.9% | 0.5% |
| EBIT | -165.2% | | | -148.9% | -154.9% |
| Pre-tax income | -159.9% | | | -200.5% | -158.5% |
| Income taxes | 0.0% | | | 0.0% | 0.0% |
| Net income | -159.9% | | | -0.2% | -0.2% |
|